A COMPARISON BETWEEN KETAMINE,CLONIDINE AND COMBINATION OF
KETAMINE-CLONIDINE FOR THE PREVENTION OF POSTANAESTHETIC
SHIVERING :
AIMS AND OBJECTIVES
To compare the efficacy of single dose intravenous ketamine (0.5mg/kg) and intravenous clonidine (1.5 mcg/kg) and combination of intravenous ketamine(0.25mg/kg) plus clonidine(0.75mcg/kg) in the prevention of shivering following general anaesthesia.
Each of these parameters are being measured for Intra-operative periods Prior Induction (Pre Operative) Immediately after intubation After 5 Mins After 10 Mins After 15 Mins After 30 Mins After 40 Mins After 50 Mins After 60 Mins End of Surgery Analysis Heart Rate (HR) Systolic Blood Pressure(SBP) Diastolic Blood Pressure(DBP) Mean Arterial Pressure(MAP) = DBP+1/3(SBP-DBP) Peripheral oxygen saturation (SPO 2 ) Capnography (ETCO 2 ) Need to compare their variation across groups and from baseline separately for each group. Adverse events are also to be compared across groups. They are
Tachycardia happens when intra-operative Heart Rate rises above 100 Bradycardia happens when intra-operative Heart Rate falls below 60Hypertension happens when the Intra-operative MAP rises 20% or more from Baseline level Hypotension happens when the Intra-operative MAP falls 20% or more from Baseline level (Pre-operative) Nausea and Vomiting (N_V)
Also check the impact on Shivering and Sedation Score. a. Need to compare Heart rate, Systolic blood pressure, diastolic blood pressure, mean arterial pressure, peripheral oxygen saturation variation across groups. ANS: Oneway anova was used to compare the variation of heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, peripheral oxygen saturation across groups. From the analysis, heartrate after 5, 10, 15, 30, 40, 50, 60, HR_EOS, HR_IND have significant variance across the groups. Therefore,the medicines which are given across the group has a significant effect on the heart rate of the patient. From the above analysis, diastolic blood pressure after 5, 10, 15, 30, 40, 50, 60, DBP_EOS, DBP_IND have significant variance across the groups. Therefore,the medicines which are given across the group has a significant effect on the heart rate of the patient. Again from the analysis, mean arterial pressure(MAP) after 5, 10, 15, 30, 40, 50, 60, MAP_EOS, MAP_IND have significant variance across the groups. Therefore,the medicines which are given across the group has a significant effect on the heart rate of the patient. Again from the analysis, SPO2(peripheral oxygen saturation) after 5, 10, 15, 30, 40, 50, 60 , SPO2_EOS, SPO2_IND dont have significant variance across the groups. Therefore,the medicines which are given across the group has no significant effect on the heart rate of the patient. Again from the analysis, we can see that ETCO2, after 5, 10, 15, 30, 40, 50, 60 , ETCO2_EOS, ETCO2_IND dont have significant variance across the groups. Therefore,the medicines which are given across the group has no significant effect on the heart rate of the patient. b. To compare the variation of HEART RATE, systolic pressure, diastolic pressure, mean arterial pressure, peripheral oxygen saturation with their baseline separately from each group. From the paired sample test, we have found that : SBP_IND-SBP_PREOP, SBP_5-SBP_PREOP. SBP_10-SBP_PREOP, SBP_15-SBP_PREOP, SBP_30-SBP_PREOP, SBP_40-SBP_PREOP, SBP_60-SBP_PREOP,DBP_EOS- DBP_PREOP,MAP_30-MAP_PREOP, MAP_EOS-MAP_PREOP have significant variation with their baseline separately from each group. HR_5-HR_PREOP, HR_10-HR_PREOP, HR_15-HR_PREOP, HR_30-HR_PREOP, HR_40- HR_PREOP, HR_50_HR_PREOP, HR_60_HR_PREOP, HR_EOS-HR_PREOP,SBP_50- SBP_PREOP,DBP_5-DBP_PREOP, DB_10-DBP_PREOP, DBP_15-DBP_PREOP, DBP30- DBP_PREOP, DBP_40-DBP_PREOP, DBP_50-DBP_PREOP,DBP_60-DBP_PREOP, MAP_5- MAP_PREOP,MAP_10-MAP_PREOP,MAP_15-MAP_PREOP,MAP_40-MAP_PREOP, MAP_50-MAP_PREOP,MAP_60_MAP_PREOP have insignificant variation with their baseline separately from each group. 2. Comparison of adverse events across group. a.TACHYCARDIA AND BRADYCARDIA.
Case Processing Summary Cases Valid Missing Total N Percent N Percent N Percent GR * HEARTDESEASE 56 46.7% 64 53.3% 120 100.0%
GR * HEARTDESEASE Crosstabulation Count HEARTDESEASE Total 1.00 2.00 GR 1 16 1 17 2 2 15 17 3 4 4 8 4 9 5 14 Total 31 25 56
Chi-Square Tests
Value df Asymp. Sig. (2- sided) Pearson Chi-Square 23.951 a 3 .000 Likelihood Ratio 27.727 3 .000 Linear-by-Linear Association 1.088 1 .297 N of Valid Cases 56
a. 2 cells (25.0%) have expected count less than 5. The minimum expected count is 3.57. Heartdesease has significant variance across. groups. Therefore bradycardia and tachycardia has sigificant variance across groups. Hence the combination of medicines has significant variance on the heartdesease.
b. Comparsion of adverse events across the group. Hypertension and hypotension
Case Processing Summary Cases Valid Missing Total N Percent N Percent N Percent GR * TENSION 120 100.0% 0 0.0% 120 100.0%
GR * TENSION Crosstabulation Count TENSION Total HYPERTENSIO N HYPOTENSION GR 1 21 9 0 30 2 15 0 15 30 3 26 0 4 30 4 15 10 5 30 Total 77 19 24 120
Chi-Square Tests Value df Asymp. Sig. (2- sided) Pearson Chi-Square 43.841 a 6 .000 Likelihood Ratio 53.131 6 .000 N of Valid Cases 120
a. 4 cells (33.3%) have expected count less than 5. The minimum expected count is 4.75. MAP has significant variance across group. Therefore hypertension and hypotension has significant variance across group. Therefore the effect of medicines on the adverse effect has significant variance.
C. COMPARISON OF ADVERSE EVENTS ACROSS GROUP. NAUSEA AND VOMMITING.
Case Processing Summary Cases Valid Missing Total N Percent N Percent N Percent GR * NAUSEAVOMITTING 120 100.0% 0 0.0% 120 100.0%
GR * NAUSEAVOMITTING Crosstabulation Count NAUSEAVOMITTING Total 1.00 2.00 GR 1 1 29 30 2 8 22 30 3 2 28 30 4 4 26 30 Total 15 105 120
Chi-Square Tests Value df Asymp. Sig. (2- sided) Pearson Chi-Square 8.762 a 3 .033 Likelihood Ratio 8.605 3 .035 Linear-by-Linear Association .136 1 .712 N of Valid Cases 120
a. 4 cells (50.0%) have expected count less than 5. The minimum expected count is 3.75. Combination of medicines has a significant effect on the physical condition on the patients. Patients having nausea vomiting is denoted by N_V and who dont have are denoted by NO.
d. Comparison of adverse events across groups. Shivering and sedation
Case Processing Summary Cases Valid Missing Total N Percent N Percent N Percent GR * SED_SCORE 120 100.0% 0 0.0% 120 100.0%
Chi-Square Tests Value df Asymp. Sig. (2- sided) Pearson Chi-Square 39.542 a 9 .000 Likelihood Ratio 39.408 9 .000 Linear-by-Linear Association 1.498 1 .221 N of Valid Cases 120
a. 8 cells (50.0%) have expected count less than 5. The minimum expected count is .25.
Case Processing Summary
Cases Valid Missing Total N Percent N Percent N Percent GR * SHIVERING 120 100.0% 0 0.0% 120 100.0%
Chi-Square Tests Value df Asymp. Sig. (2- sided) Pearson Chi-Square 63.069 a 12 .000 Likelihood Ratio 59.709 12 .000 Linear-by-Linear Association 3.022 1 .082 N of Valid Cases 120
a. 4 cells (20.0%) have expected count less than 5. The minimum expected count is .25.
Here the combination of medicines has a significant effect on the physical condition like shivering of the patients and significant variance was found. Also sedation has a significant variance across group.